Welcome to our dedicated page for Ncs Multistage Hldgs SEC filings (Ticker: NCSM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The NCS Multistage Holdings, Inc. (NASDAQ: NCSM) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. NCS Multistage operates in support activities for oil and gas operations, supplying highly engineered products and support services for oil and natural gas well construction, well completions and field development strategies. Its filings offer detail on how this business is performing and evolving over time.
Among the key documents are current reports on Form 8-K, which NCS Multistage uses to announce material events such as quarterly financial results. For example, the company has filed 8-K reports to furnish press releases covering results for quarters ended June 30, 2025 and September 30, 2025. These filings typically include information on revenues, net income, adjusted EBITDA and commentary on regional activity in markets such as the United States, Canada and selected international regions.
In addition to 8-Ks, investors commonly review annual reports on Form 10-K and quarterly reports on Form 10-Q, where available, to understand segment performance, risk factors, and details related to products and services like tracer diagnostics and reservoir analysis. Proxy statements can provide information on governance and executive compensation, while registration statements and other filings may address capital structure and financing activities.
On Stock Titan, these SEC filings are paired with AI-powered summaries that highlight the main points of lengthy documents, helping users interpret complex disclosures. Real-time updates from the SEC’s EDGAR system ensure that new NCS Multistage filings, including Forms 10-K, 10-Q and 8-K, appear promptly. Users can also review insider transaction reports on Form 4 when available, gaining additional insight into trading activity by NCS Multistage officers and directors.
NCS Multistage Holdings director John D. Deane received an award of 3,221 shares of common stock on March 3, 2026 through a grant or similar acquisition at no stated price. Following this award, his directly held common stock totaled 32,771 shares, including 3,221 restricted stock units that vest and settle on February 28, 2027.
The filing also reports 10,731 shares of common stock held indirectly by the Deane Family Partnership Limited, a limited partnership for which Deane is the sole general partner. He disclaims beneficial ownership of these indirectly held securities except to the extent of his pecuniary interest in them.
NCS Multistage Holdings director Robert Nipper reported an equity award and updated his holdings. He acquired 3,221 shares of common stock at a price of $0.00 per share as a grant or award, increasing his directly held common stock to 36,676 shares. The 3,221-share award consists of restricted stock units that vest and settle on February 28, 2027. Indirectly, 88,596 shares are held by the Nipper Family Limited Partnership, where he is trustee of the sole general partner, and he disclaims beneficial ownership except for his pecuniary interest.
Mitchell Valerie A reported acquisition or exercise transactions in this Form 4 filing.
NCS Multistage Holdings director Valerie A. Mitchell received an equity award of 3,221 shares of common stock in the form of restricted stock units. These units were granted at no cash cost and increase her direct holdings to 26,772 shares. The 3,221 restricted stock units vest and settle on February 28, 2027, while 19,212 previously vested restricted stock units are scheduled to settle within thirty days after her service ends or a change of control, whichever occurs first.
RALLS W MATT reported acquisition or exercise transactions in this Form 4 filing.
NCS Multistage Holdings director W. Matt Ralls received a grant of 3,221 shares of common stock in the form of restricted stock units at a price of $0.00 per share. These units vest on February 28, 2027.
After this award, he holds 31,065 shares directly, including 3,221 unvested restricted stock units and 25,256 vested restricted stock units that will be settled in shares within thirty days after the earlier of his service ending for any reason or a change of control.
Grewal Gurinder reported acquisition or exercise transactions in this Form 4 filing.
NCS Multistage Holdings, Inc. director Gurinder Grewal reported an equity award of 3,221 shares of common stock in the form of a grant. These restricted stock units vest on February 28, 2027. After this award, Grewal directly holds 20,919 shares, including 17,698 vested restricted stock units that settle within thirty days after service ends or a change of control.
NCS Multistage Holdings (NCSM) reported an insider transaction by a director. On 11/05/2025, the director sold 1,000 shares of common stock at $40 per share. Following the sale, the director beneficially owns 33,455 shares directly and 88,596 shares indirectly through a family limited partnership. The footnotes state that direct holdings include 4,339 restricted stock units scheduled to vest on February 28, 2026, and describe the indirect ownership structure through the Nipper Family Limited Partnership.
NCS Multistage Holdings (NCSM) disclosed an insider transaction on a Form 4. A director reported selling 3,147 shares of common stock on 11/03/2025 at a weighted average price within $40.00–$40.36. Following the sale, 88,596 shares were beneficially owned indirectly through a family limited partnership.
The filing also notes 34,455 shares held directly, which include 4,339 restricted stock units scheduled to vest on February 28, 2026.
NCS Multistage Holdings (NCSM) reported insider activity by its CFO & Treasurer on November 1, 2025. The filing shows the vesting of 1,877 equivalent stock units that were settled for cash, paired with an option exercise (code M) delivering 1,877 common shares at $0. To cover taxes, 1,877 shares were disposed at $36.70 (code F), alongside an additional disposition of 458 shares at $36.70 (code D). After these transactions, the officer held 7,479 common shares directly and 11,015 equivalent stock units as derivatives.
NCS Multistage Holdings (NCSM) reported insider activity by its Chief Executive Officer and Director on 11/01/2025.
The reporting person acquired 4,226 shares of common stock via a code M transaction, then surrendered 4,226 shares in a code F transaction to satisfy tax obligations related to restricted stock unit vesting, and disposed of 1,030 shares at $36.7. Following these transactions, the insider directly beneficially owned 33,383 shares.
Derivative holdings included equivalent stock units with 22,834 units beneficially owned following the reported transactions. Context: the ownership includes 7,240 restricted stock units that vest in three equal annual installments beginning on February 28, 2026, and equivalent stock units that vest in scheduled installments as disclosed.
NCS Multistage Holdings (NCSM) posted a solid Q3 2025 with revenue of $46.5 million compared with $44.0 million a year ago. Income from operations was $3.1 million, and net income attributable to NCS was $3.8 million, or $1.37 diluted EPS versus $1.60 last year.
For the first nine months, revenue reached $133.0 million (up from $117.6 million) and net income attributable to NCS rose to $8.8 million from $3.1 million. Operating cash flow was $9.0 million. NCS ended the quarter with $25.3 million in cash, $7.4 million of finance-lease debt, and no ABL borrowings; total equity was $127.1 million.
NCS acquired Reservoir Metrics (ResMetrics) on July 31, 2025 for total consideration of $7.1 million, including contingent consideration tied to tariff changes. ResMetrics contributed $2.2 million of revenue and $0.6 million of income before tax for the period ended September 30, 2025. In Canada patent matters, the Federal Court of Appeal set aside a prior injunction and reduced a costs award to approximately $0.9 million, remanding the case to the trial court.